Evidence map›Paper›PMID 42570123›Full record

ArticleJournal of robotic surgery2026

Comparison of postoperative and early oncological outcomes of open versus robotic radical cystectomy.

Charis Eleftheriou, Yi Zhao, Mariam Lami, Ranil Johann Boaz, Adham Moftah, Katherine Jurdon, Anas Khan, Norma Gibbons, Giles Hellawell, Eva Bolton and 1 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Charis EleftheriouCharing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Yi ZhaoBarts Health NHS Trust, London, UK. yi.zhao3@nhs.net.
Mariam LamiRoyal Marsden Hospital, London, UK.
Ranil Johann BoazCharing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Adham MoftahCharing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Katherine JurdonCharing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Anas KhanAshford and St. Peter's Hospitals NHS Foundation Trust, Surrey, UK.
Norma GibbonsCharing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Giles HellawellCharing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Eva BoltonCharing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Rakesh HeerCharing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To compare the peri-operative and early oncological outcomes between open radical cystectomy and urinary diversion versus robotic radical cystectomy with intracorporal urinary diversion in a large UK regional cystectomy centre. All patients between January 2020 and June 2024 who underwent a radical cystectomy and urinary diversion were identified for a retrospective cohort study. Peri-operative outcomes were compared between the open and robotic groups. Early oncological outcomes, including overall survival, progression-free survival, and cancer-specific survival were analysed at 8 months. There were no significant differences in early oncological outcomes between ORC and RARC. However, the robotic approach was associated with significantly lower estimated blood loss, reduced transfusion rates, and shorter length of hospital stay compared with the open approach. Rates of post-operative complications, as well as 30-day and 90-day readmissions, were comparable between the two groups. Robotic-assisted radical cystectomy demonstrated superior peri-operative outcomes in terms of reduced blood loss, lower transfusion requirements and shorter hospital stay without compromising early oncological outcomes. Further research is required to determine whether these peri-operative advantages translate into long-term oncological benefit and improved quality-adjusted life years sufficient to justify the increased procedural costs associated with the robotic approach.

Indexed as

CystectomyRobotic Surgical ProceduresUrinary Bladder NeoplasmsUrinary DiversionAgedBlood Loss, SurgicalBlood TransfusionFemaleHumansLength of StayMaleMiddle AgedPostoperative ComplicationsRetrospective StudiesTreatment OutcomeBladder cancerIntracorporeal urinary diversionMinimally invasive surgeryOncological outcomesOpen radical cystectomyPeri-operative outcomesRobotic-assisted radical cystectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.